Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.

Chen KH, Wada M, Pinz KG, Liu H, Lin KW, Jares A, Firor AE, Shuai X, Salman H, Golightly M, Lan F, Senzel L, Leung EL, Jiang X, Ma Y.

Leukemia. 2017 Feb 10. doi: 10.1038/leu.2017.8. [Epub ahead of print]

PMID:
28074066
2.

Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.

Chen KH, Wada M, Firor AE, Pinz KG, Jares A, Liu H, Salman H, Golightly M, Lan F, Jiang X, Ma Y.

Oncotarget. 2016 Aug 30;7(35):56219-56232. doi: 10.18632/oncotarget.11019.

3.

Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.

Pinz K, Liu H, Golightly M, Jares A, Lan F, Zieve GW, Hagag N, Schuster M, Firor AE, Jiang X, Ma Y.

Leukemia. 2016 Mar;30(3):701-7. doi: 10.1038/leu.2015.311.

PMID:
26526988
4.

Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas.

Campian JL, Ye X, Gladstone DE, Ambady P, Nirschl TR, Borrello I, Golightly M, King KE, Holdhoff M, Karp J, Drake CG, Grossman SA.

J Neurooncol. 2015 Sep;124(2):307-16. doi: 10.1007/s11060-015-1841-y.

5.

Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).

Pearl ML, Dong H, Tulley S, Zhao Q, Golightly M, Zucker S, Chen WT.

Gynecol Oncol. 2015 May;137(2):229-38. doi: 10.1016/j.ygyno.2015.03.002.

PMID:
25769657
6.

Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.

Pearl ML, Zhao Q, Yang J, Dong H, Tulley S, Zhang Q, Golightly M, Zucker S, Chen WT.

Gynecol Oncol. 2014 Sep;134(3):581-90. doi: 10.1016/j.ygyno.2014.06.013.

7.

Iraq dust is respirable, sharp, and metal-laden and induces lung inflammation with fibrosis in mice via IL-2 upregulation and depletion of regulatory T cells.

Szema AM, Reeder RJ, Harrington AD, Schmidt M, Liu J, Golightly M, Rueb T, Hamidi SA.

J Occup Environ Med. 2014 Mar;56(3):243-51. doi: 10.1097/JOM.0000000000000119.

8.

Effects of hydration status on cognitive performance and mood.

Masento NA, Golightly M, Field DT, Butler LT, van Reekum CM.

Br J Nutr. 2014 May 28;111(10):1841-52. doi: 10.1017/S0007114513004455. Review.

PMID:
24480458
9.

Effects of 100MeV protons delivered at 0.5 or 1cGy/min on the in vivo induction of early and delayed chromosomal damage.

Rithidech KN, Honikel LM, Reungpatthanaphong P, Tungjai M, Golightly M, Whorton EB.

Mutat Res. 2013 Aug 30;756(1-2):127-40. doi: 10.1016/j.mrgentox.2013.06.001.

PMID:
23770023
10.

Lymphoproliferative disorder that resembles heptosplenic lymphoma during maintenance treatment for T-cell acute lymphoblastic leukemia.

Hu Y, Ahmed T, Zaslav AL, Golightly M, Spitzer SG, Raetz E, Chan EL.

Pediatr Blood Cancer. 2013 Jun;60(6):E10-2. doi: 10.1002/pbc.24442.

PMID:
23303724
11.

Pediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expression.

Bellone M, Svensson AM, Zaslav AL, Spitzer S, Golightly M, Celiker M, Hu Y, Ma Y, Ahmed T.

Exp Hematol Oncol. 2012 Apr 18;1(1):7. doi: 10.1186/2162-3619-1-7.

12.

A family with Bolzano-type Bernard-Soulier syndrome carries a benign A1939T MYH9 mutation.

Sarangi SN, Golightly M, Weber J, Chan EL.

Platelets. 2013;24(1):81-4. doi: 10.3109/09537104.2012.658108. No abstract available.

PMID:
22372535
13.

Myelofibrosis involving lymph node: a novel cytogenetic abnormality in a mimicker of mesenchymal neoplasm.

Hu Y, Zaslav AL, Radhakrishnan N, Golightly M, Pameijer C.

J Hematop. 2009 Jun 30;2(3):157-61. doi: 10.1007/s12308-009-0040-1.

14.

Analysis of cell cycle in mouse bone marrow cells following acute in vivo exposure to 56Fe ions.

Rithidech KN, Golightly M, Whorton E.

J Radiat Res. 2008 Jul;49(4):437-43.

15.

Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential.

Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS.

Circulation. 2002 Oct 29;106(18):2372-8.

16.

Laboratory diagnosis of autoimmune diseases.

Golightly M, Golightly C.

MLO Med Lab Obs. 2002 Jul;34(7):12-6, 20; quiz 22-3. No abstract available.

PMID:
12134551
17.

Vitronectin is sequestered within human spermatozoa and liberated following the acrosome reaction.

Bronson R, Peresleni T, Golightly M, Preissner K.

Mol Hum Reprod. 2000 Nov;6(11):977-82.

PMID:
11044459
18.
19.

Cell-mediated immunity in allopurinol-induced hypersensitivity.

Braden GL, Warzynski MJ, Golightly M, Ballow M.

Clin Immunol Immunopathol. 1994 Feb;70(2):145-51.

PMID:
8299230
20.

Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group.

Halperin JJ, Golightly M.

Neurology. 1992 Jul;42(7):1268-70.

PMID:
1620330
Items per page

Supplemental Content

Loading ...
Support Center